AR and neoplasm: These inconsistent data on the rate of AR expression and its associations with tumor grades/stages or prognosis among studies might have resulted from differences or lack of standardization in, for example, tissue preservation (e.g., timing of fixation), staining protocol (e.g., antibody), and immunoreactivity scoring.